IN 2016, 2018, 2020, and 2022, voters approved a raft of drug policy reforms. They included legalization of recreational marijuana in 11 states, authorization of medical use in eight, decriminalization of low-level drug possession in Oregon, approval of “psilocybin service centers” in the same state, and decriminalization of five naturally occurring psychedelics in Colorado.
The 2024 election results were a different story. Legalization of recreational marijuana lost in Florida, North Dakota, and South Dakota. Nebraska voters over-whelmingly approved medical marijuana, but a pending legal challenge may prevent implementation of that policy. A Massachusetts psychedelic initiative similar to Colorado’s went down by a double-digit margin. And California voters resoundingly approved an initiative that increased penalties for several drug offenses, reinforcing the message that Oregon legislators sent when they overturned decriminalization in…
